|
WO1998024479A1
(en)
|
1996-12-02 |
1998-06-11 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated delivery of dna to cells of the liver
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
US7238346B2
(en)
|
2002-07-08 |
2007-07-03 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
High capacity recombinant adenoviral vector for treatment of hemophilia A
|
|
ATE484591T1
(de)
|
2003-10-21 |
2010-10-15 |
Merck Serono Sa |
Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression
|
|
WO2006043354A1
(ja)
|
2004-10-20 |
2006-04-27 |
National Institute Of Radiological Sciences |
組込型の低線量放射線誘導性ベクター
|
|
JP2008543283A
(ja)
|
2005-06-10 |
2008-12-04 |
ジェネンテック・インコーポレーテッド |
インスレーターエレメントを含むベクターを使用する抗体発現の改良
|
|
JP2011502478A
(ja)
|
2007-11-01 |
2011-01-27 |
ユニバーシティー オブ ロチェスター |
安定性が増大した組換え型第ｖｉｉｉ因子
|
|
DK2282764T3
(da)
|
2008-04-22 |
2019-10-14 |
Vib Vzw |
Leverspecifikke nukleinsyreregulerende elementer samt fremgangsmåder og anvendelser heraf
|
|
WO2009134681A2
(en)
*
|
2008-04-30 |
2009-11-05 |
The Trustees Of The University Of Pennsylvania |
Aav7 viral vectors for targeted delivery of rpe cells
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
US9150847B2
(en)
|
2011-09-21 |
2015-10-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of transgene expression
|
|
JP2015501844A
(ja)
*
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
EP2804623B1
(en)
|
2012-01-12 |
2019-08-07 |
Bioverativ Therapeutics Inc. |
Chimeric factor viii polypeptides and uses thereof
|
|
CA2875618C
(en)
|
2012-07-11 |
2021-04-27 |
Sangamo Biosciences, Inc. |
Methods and compositions for the treatment of lysosomal storage diseases
|
|
JP2015529466A
(ja)
|
2012-09-14 |
2015-10-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター
|
|
AU2013336601B2
(en)
|
2012-10-26 |
2018-01-25 |
Vrije Universiteit Brussel |
Vector for liver-directed gene therapy of hemophilia and methods and use thereof
|
|
AU2014246731A1
(en)
|
2013-03-30 |
2015-11-19 |
Usha Biotech Limited |
Methods and constructs for expressing biologically active proteins in mammalian cells
|
|
EP3770169A1
(en)
|
2013-09-12 |
2021-01-27 |
BioMarin Pharmaceutical Inc. |
Adeno-associated virus factor viii vectors
|
|
ES2813367T3
(es)
|
2013-12-09 |
2021-03-23 |
Sangamo Therapeutics Inc |
Métodos y composiciones para ingeniería genómica
|
|
SG11201605242YA
(en)
|
2014-01-10 |
2016-07-28 |
Biogen Ma Inc |
Factor viii chimeric proteins and uses thereof
|
|
WO2016127057A1
(en)
|
2015-02-06 |
2016-08-11 |
The University Of North Carolina At Chapel Hill |
Optimized human clotting factor viii gene expression cassettes and their use
|
|
EP3283126B1
(en)
*
|
2015-04-16 |
2019-11-06 |
Emory University |
Recombinant promoters and vectors for protein expression in liver and use thereof
|
|
AU2016259710B2
(en)
|
2015-05-11 |
2020-08-27 |
Basf Se |
Herbicide combinations comprising L-glufosinate and indaziflam
|
|
CN108024544B
(zh)
|
2015-07-13 |
2022-04-29 |
桑格摩生物治疗股份有限公司 |
用于核酸酶介导的基因组工程化的递送方法及组合物
|
|
PE20181338A1
(es)
*
|
2015-09-24 |
2018-08-21 |
Biomarin Pharm Inc |
Vectores del factor viii del virus adeno-asociado, particulas viricas asociadas y formulaciones terapeuticas que los comprenden
|
|
CN115141836B
(zh)
*
|
2015-10-28 |
2024-08-27 |
桑格摩生物治疗股份有限公司 |
肝特异性构建体、因子viii表达盒及其使用方法
|
|
CN116479001A
(zh)
*
|
2015-11-13 |
2023-07-25 |
武田药品工业株式会社 |
用于血友病a的基因治疗的具有增加的表达的编码重组fviii变体的病毒载体
|
|
KR20240160648A
(ko)
*
|
2017-08-01 |
2024-11-11 |
스파크 테라퓨틱스, 인코포레이티드 |
인자 viii (fviii) 유전자 요법 방법
|